集成微流控细胞共培养系统和模拟药物的代谢
详细信息    查看官网全文
摘要
本研究以微流控芯片为平台,进行前体药物伊立替康(CPT-11)的肠细胞吸收、靶细胞作用和肝细胞代谢协同药物代谢研究:分别以人结肠癌Caco-2细胞群体来模拟小肠对药物吸收,以HepG2肝癌细胞群体模拟肝脏对药物的代谢[1]。CPT-11需要经过Caco2细胞吸收,HepG2细胞代谢形成活性中间产物7-乙基-10-羟基喜树碱(SN-38),活性药物再进入靶器官U251细胞代谢产生抗癌效果。利用荧光检测、流式细胞仪和液相色谱与串联质谱等技术检测药物代谢过程中的代谢产物[2],构建功能化的药物代谢微流控芯片系统,实现细胞间药物转运与化学信号传递的监控。这一3D装置可推广用于体外药物筛选及个性化癌症治疗的研究。
In this work,a multi-type cell microfluidic integrator for cocultivation enabling simulation of drug absorption,metabolism,and anticancer activity was developed.To organize an in vitro drug absorption and metabolism model,Caco-2,HepG2,and U251 cells were co-cultured as mimic organs of the intestine,liver,and glioblastoma,respectively.The drug cytotoxicity assay was monitored by fluorescence visualization.The extra-/intra-cellular CPT-11 and its active metabolite of 7-ethyl-10-hydroxycamptothecin(SN-38) were qualitatively and quantitatively characterized by liquid chromatography-tandem mass spectrometry.Our results suggested that this dynamic 3D device provided a potential application for high throughput drug screening and personalized cancer therapy.
引文
[1]Esch,E.W.;Bahinski,A.;Huh,D.Nat Rev Drug Discov.2015,14:248.
    [2]Mao,S.;Zhang,J.;Li,H.;Lin,J.-M..Anal.Chem..2013,85:868.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700